iifl-logo

Nippon India Pharma Fund Bonus

Nippon India Pharma Fund Bonus

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Pharma Fund Bonus

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

10-May-2004

Fund Manager

Sailesh Raj Bhan

Net Assets (Rs. cr)

9044.23

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Nippon India Pharma Fund Bonus - Nav Details

Nav Date

:  13-Jul-2026

NAV [Rs.]

:  561.0211

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nippon India Pharma Fund Bonus- NAV Chart

Nippon India Pharma Fund Bonus- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.67
4.17
12.92
10.47
8.77
20.33
12.52
19.97
Category Avg
0.08
5.37
16.78
15.11
13.41
23.08
14.48
17.04
Category Best
1.74
7.1
21.43
23.26
21.89
26.92
17.56
31.45
Category Worst
-0.72
4.17
10.01
5.62
4.64
18.9
10.85
5.23

Nippon India Pharma Fund Bonus- Latest Dividends

No Records Found

Nippon India Pharma Fund Bonus- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Piramal Pharma55,00,000

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.7862063491,155.93
EquityLupinPharmaceuticals & Biotechnology7.452783991673.44
EquityDr Reddy's LabsPharmaceuticals & Biotechnology6.684449746603.87
EquityCiplaPharmaceuticals & Biotechnology6.153795054556.12
EquityDivi's Lab.Pharmaceuticals & Biotechnology5.46750754493.92
EquityApollo HospitalsHealthcare Services5.27548795476.46
EquityMankind PharmaPharmaceuticals & Biotechnology4.031431195364.32
EquitySai LifePharmaceuticals & Biotechnology3.492555745315.45
EquityAjanta PharmaPharmaceuticals & Biotechnology3.46913918312.80
EquityMax HealthcareHealthcare Services3.322658082300.16
EquityMedplus HealthRetailing3.183545229287.42
EquityVijaya Diagnost.Healthcare Services2.801871618253.15
EquityThyrocare Tech.Healthcare Services2.654366909239.87
EquityIpca Labs.Pharmaceuticals & Biotechnology2.571364742232.14
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology2.47913226223.76
EquityGland PharmaPharmaceuticals & Biotechnology2.21800549199.73
EquityAbbott IndiaPharmaceuticals & Biotechnology2.0974339189.11
EquityAlkem LabPharmaceuticals & Biotechnology1.99323678180.28
EquityDr Lal PathlabsHealthcare Services1.851018224167.62
EquityNarayana HrudayaHealthcare Services1.80823911162.45
EquityAurobindo PharmaPharmaceuticals & Biotechnology1.751002630158.28
EquitySyngene Intl.Healthcare Services1.703501497153.89
EquityPfizerPharmaceuticals & Biotechnology1.56318249141.28
EquityEmcure PharmaPharmaceuticals & Biotechnology1.52746337137.02
EquityFortis Health.Healthcare Services1.421346128128.81
EquitySuraksha Diagno.Healthcare Services1.183896349106.35
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.0921365998.21
EquityAkums DrugsPharmaceuticals & Biotechnology1.03148931792.80
EquityPiramal PharmaPharmaceuticals & Biotechnology1.02550000092.44
EquityAnthem BiosciencPharmaceuticals & Biotechnology0.90105850381.56
EquitySanofi IndiaPharmaceuticals & Biotechnology0.8723027278.43
EquityBioconPharmaceuticals & Biotechnology0.68146937461.46
EquityAstrazeneca PharPharmaceuticals & Biotechnology0.576256851.47
EquityIndoco RemediesPharmaceuticals & Biotechnology0.49183492443.89
EquityConcord BiotechPharmaceuticals & Biotechnology0.1611173814.30

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.